Recombinant Human MAT2b Protein，His

MAT2b, or Methionine Adenosyltransferase 2B, is a critical enzyme involved in the biosynthesis of S-adenosylmethionine (SAM), a universal methyl donor important for numerous biological processes, including methylation of DNA, proteins, and lipids. Research on MAT2b has gained attention due to its significant role in liver metabolism and its implications in various diseases, including liver cancer, metabolic disorders, and neurological conditions. The identification and characterization of MAT2b as a potential therapeutic target stem from its dysregulation in various pathologies. Furthermore, studies have shown that MAT2b expression levels can influence cellular proliferation and apoptosis, thus linking it to tumorigenesis. Recombinant MAT2b protein studies aim to elucidate its structural and functional properties, which can provide critical insights into its enzymatic mechanisms and interactions with substrates and inhibitors. Understanding MAT2b's role at a molecular level is essential for developing specific modulators that could serve as therapeutic agents in disorders associated with SAM metabolism. The ongoing research in recombinant protein production of MAT2b not only facilitates a deeper understanding of its biological functions but also opens avenues for novel treatment strategies targeting SAM-related pathways.